INTRODUCTION: Neurocognitive impairment is common to several neuropsychiatric disorders. The growing use of cognitive impairment as an intermediate phenotype, or "endophenotype", in psychiatry raises the issue of whether global measures of cognition, such as IQ, or assays of more specific cognitive domains, such as working memory, will best serve to enhance power in detecting susceptibility loci in molecular genetic studies. METHODS: This paper will review the research on general intelligence in schizophrenia and bipolar disorder and evaluate its strengths and weaknesses as a candidate intermediate phenotype. RESULTS: Although global measures of cognition may not be optimal as intermediate phenotypes in bipolar disorder, certain clinical traits that overlap between schizophrenia and bipolar disorder, such as psychosis, may be predictive of poor performance on global measures, regardless of DSM-IV categorisation. CONCLUSIONS: Global measures of cognition represent good intermediate phenotypes in schizophrenia. Current research does not support the use of global measures of cognition as intermediate phenotypes for bipolar disorder. Assays of specific neurocognitive domains may have greater potential to detect genetic markers for bipolar disorder.
INTRODUCTION:Neurocognitive impairment is common to several neuropsychiatric disorders. The growing use of cognitive impairment as an intermediate phenotype, or "endophenotype", in psychiatry raises the issue of whether global measures of cognition, such as IQ, or assays of more specific cognitive domains, such as working memory, will best serve to enhance power in detecting susceptibility loci in molecular genetic studies. METHODS: This paper will review the research on general intelligence in schizophrenia and bipolar disorder and evaluate its strengths and weaknesses as a candidate intermediate phenotype. RESULTS: Although global measures of cognition may not be optimal as intermediate phenotypes in bipolar disorder, certain clinical traits that overlap between schizophrenia and bipolar disorder, such as psychosis, may be predictive of poor performance on global measures, regardless of DSM-IV categorisation. CONCLUSIONS: Global measures of cognition represent good intermediate phenotypes in schizophrenia. Current research does not support the use of global measures of cognition as intermediate phenotypes for bipolar disorder. Assays of specific neurocognitive domains may have greater potential to detect genetic markers for bipolar disorder.
Authors: Claire Daban; Anabel Martinez-Aran; Carla Torrent; Rafael Tabarés-Seisdedos; Vicent Balanzá-Martínez; Jose Salazar-Fraile; Gabriel Selva-Vera; Eduard Vieta Journal: Psychother Psychosom Date: 2006 Impact factor: 17.659
Authors: T D Cannon; M O Huttunen; J Lonnqvist; A Tuulio-Henriksson; T Pirkola; D Glahn; J Finkelstein; M Hietanen; J Kaprio; M Koskenvuo Journal: Am J Hum Genet Date: 2000-07-03 Impact factor: 11.025
Authors: Lucy J Robinson; Jill M Thompson; Peter Gallagher; Utpal Goswami; Allan H Young; I Nicol Ferrier; P Brian Moore Journal: J Affect Disord Date: 2006-03-06 Impact factor: 4.839
Authors: Chelsie E Benca; Jaime L Derringer; Robin P Corley; Susan E Young; Matthew C Keller; John K Hewitt; Naomi P Friedman Journal: Behav Genet Date: 2016-10-14 Impact factor: 2.805
Authors: Tristram A Lett; Bob O Vogel; Stephan Ripke; Carolin Wackerhagen; Susanne Erk; Swapnil Awasthi; Vassily Trubetskoy; Eva J Brandl; Sebastian Mohnke; Ilya M Veer; Markus M Nöthen; Marcella Rietschel; Franziska Degenhardt; Nina Romanczuk-Seiferth; Stephanie H Witt; Tobias Banaschewski; Arun L W Bokde; Christian Büchel; Erin B Quinlan; Sylvane Desrivières; Herta Flor; Vincent Frouin; Hugh Garavan; Penny Gowland; Bernd Ittermann; Jean-Luc Martinot; Marie-Laure Paillère Martinot; Frauke Nees; Dimitri Papadopoulos-Orfanos; Tomáš Paus; Luise Poustka; Juliane H Fröhner; Michael N Smolka; Robert Whelan; Gunter Schumann; Heike Tost; Andreas Meyer-Lindenberg; Andreas Heinz; Henrik Walter Journal: Cereb Cortex Date: 2020-04-14 Impact factor: 4.861
Authors: Mădălina Vrabie; Victor Marinescu; Anca Talaşman; Oana Tăutu; Eduard Drima; Ioana Micluţia Journal: Ann Gen Psychiatry Date: 2015-11-25 Impact factor: 3.455